BONE MARROW FAILURE
Clinical trials for BONE MARROW FAILURE explained in plain language.
Never miss a new study
Get alerted when new BONE MARROW FAILURE trials appear
Sign up with your email to follow new studies for BONE MARROW FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Veto cells may help donor stem cells take hold without dangerous side effects
Disease control OngoingThis study tests whether adding special 'veto' cells to a stem cell transplant can help donor cells grow in the body without causing severe graft-versus-host disease (GVHD). It includes 16 people aged 12-75 with various blood cancers or bone marrow failure. The veto cells are tre…
Matched conditions: BONE MARROW FAILURE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
New hope for rare bone marrow failure: experimental drug EXG34217 enters human testing
Disease control OngoingThis early-stage study tests a new drug called EXG34217 in 12 people aged 12 and older who have bone marrow failure due to telomere biology disorders. The main goal is to check if the drug is safe and tolerable. Researchers will also look for improvements in blood cell counts and…
Matched conditions: BONE MARROW FAILURE
Phase: PHASE1 • Sponsor: Elixirgen Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 11:09 UTC